Mitochondrial uncoupling protein-2 reprograms metabolism to induce oxidative stress and myofibroblast senescence in age-associated lung fibrosis.
Aging Cell.
2022 Sep;21(9):e13674. doi: 10.1111/acel.13674. Epub 2022 Aug 7. PubMed PMID:
35934931; PubMed Central PMCID:
PMC9470902.
Restoration of SIRT3 gene expression by airway delivery resolves age-associated persistent lung fibrosis in mice.
Nat Aging.
2021 Feb;1(2):205-217. doi: 10.1038/s43587-021-00027-5. Epub 2021 Feb 11. PubMed PMID:
34386777; PubMed Central PMCID:
PMC8357317.
Oxidative cross-linking of fibronectin confers protease resistance and inhibits cellular migration.
Sci Signal.
2020 Aug 11;13(644). doi: 10.1126/scisignal.aau2803. PubMed PMID:
32788339; PubMed Central PMCID:
PMC9394744.
Remember Me? The Bone Marrow in Pulmonary Fibrosis.
Am J Respir Crit Care Med.
2019 Oct 15;200(8):959-960. doi: 10.1164/rccm.201906-1101ED. PubMed PMID:
31206314; PubMed Central PMCID:
PMC6794115.
Metformin reverses established lung fibrosis in a bleomycin model.
Nat Med.
2018 Aug;24(8):1121-1127. doi: 10.1038/s41591-018-0087-6. Epub 2018 Jul 2. PubMed PMID:
29967351; PubMed Central PMCID:
PMC6081262.
The TAMing of the Idiopathic Pulmonary Fibrosis Myofibroblast. One Step Closer?.
Am J Respir Crit Care Med.
2018 Jun 1;197(11):1377-1378. doi: 10.1164/rccm.201802-0222ED. PubMed PMID:
29664671.
Mitochondrial Dysfunction in Pulmonary Fibrosis.
Ann Am Thorac Soc.
2017 Nov;14(Supplement_5):S383-S388. doi: 10.1513/AnnalsATS.201705-370AW. Review. PubMed PMID:
29161077; PubMed Central PMCID:
PMC5711275.
Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients.
J Heart Lung Transplant.
2017 Jul 15;. doi: 10.1016/j.healun.2017.07.007. [Epub ahead of print] PubMed PMID:
28756121; PubMed Central PMCID:
PMC5893420.
3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.
JCI Insight.
2017 Apr 20;2(8). doi: 10.1172/jci.insight.94088. eCollection 2017 Apr 20. PubMed PMID:
28422764; PubMed Central PMCID:
PMC5396517.
3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.
JCI Insight.
2017 Jan 26;2(2):e91377. doi: 10.1172/jci.insight.91377. PubMed PMID:
28138565; PubMed Central PMCID:
PMC5256136.
Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis.
Sci Rep.
2016 Nov 21;6:37445. doi: 10.1038/srep37445. PubMed PMID:
27869174; PubMed Central PMCID:
PMC5116673.
The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
FASEB J.
2016 Jun;30(6):2135-50. doi: 10.1096/fj.201500173. Epub 2016 Feb 16. PubMed PMID:
26884454; PubMed Central PMCID:
PMC4871800.
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?.
Drugs.
2016 Mar;76(3):291-300. doi: 10.1007/s40265-015-0523-6. Review. PubMed PMID:
26729185; PubMed Central PMCID:
PMC4939080.
Novel Mechanisms for the Antifibrotic Action of Nintedanib.
Am J Respir Cell Mol Biol.
2016 Jan;54(1):51-9. doi: 10.1165/rcmb.2014-0445OC. PubMed PMID:
26072676; PubMed Central PMCID:
PMC4742925.
Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation.
J Biol Chem.
2015 Oct 16;290(42):25427-38. doi: 10.1074/jbc.M115.646984. Epub 2015 Aug 28. PubMed PMID:
26318453; PubMed Central PMCID:
PMC4646190.
SMAD-independent down-regulation of caveolin-1 by TGF-β: effects on proliferation and survival of myofibroblasts.
PLoS One.
2015;10(2):e0116995. doi: 10.1371/journal.pone.0116995. eCollection 2015. PubMed PMID:
25658089; PubMed Central PMCID:
PMC4319960.
Restless legs syndrome in an Indian urban population.
Sleep Med.
2007 Dec;9(1):88-93. doi: 10.1016/j.sleep.2006.11.004. Epub 2007 Sep 6. PubMed PMID:
17825618.
Restless legs syndrome in Indian patients having iron deficiency anemia in a tertiary care hospital.
Sleep Med.
2007 Apr;8(3):247-51. doi: 10.1016/j.sleep.2006.10.004. Epub 2007 Mar 26. PubMed PMID:
17368978.
What would you like to do?